Vani X. Oliveira
Aracui, ES, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
TcGAPDH peptidic inhibitors derived from dinoponeratoxin M-PONTX-Dq4e with trypanocidal effect.
Journal: Toxicon : official journal of the International Society on Toxinology
Published: September 24, 2025
Engineering the Host Defense Peptide from Scorpion Venom for Safer and More Potent Antibreast Cancer Activity.
Journal: ACS pharmacology & translational science
Published: August 29, 2025
Evaluation of the Antitumor and Antiproliferative Potential of Synthetic Peptides Derived from IsCT1, Associated with Cisplatin, in Squamous Cell Carcinoma of the Oral Cavity.
Journal: Molecules (Basel, Switzerland)
Published: April 29, 2025
Antitumoral and Antiproliferative Potential of Synthetic Derivatives of Scorpion Peptide IsCT1 in an Oral Cavity Squamous Carcinoma Model.
Journal: Molecules (Basel, Switzerland)
Published: July 12, 2024
Synthetic angiotensin II peptide derivatives confer protection against cerebral and severe non-cerebral malaria in murine models.
Journal: Scientific reports
Published: October 20, 2023
Effect from dinoponeratoxin M-PONTXDq3a arginine and lysine substituted analogues against Staphylococcus aureus strains.
Journal: Toxicon : official journal of the International Society on Toxinology
Published: March 04, 2023
The BR2 peptide associated with 2-aminoethyl dihydrogen phosphate is a formulation with antiproliferative potential for a triple-negative breast cancer model.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 13, 2022
The wasp venom antimicrobial peptide polybia-CP and its synthetic derivatives display antiplasmodial and anticancer properties.
Journal: Bioengineering & translational medicine
Published: March 23, 2020
Last Updated: 09/26/2026